EW - Edwards Lifesciences Corp
83.89
-1.330 -1.585%
Share volume: 6,372,442
Last Updated: 03-05-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$85.22
-1.33
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 04-29-2024 | 07-31-2024 | 11-06-2024 | 02-28-2025 | 05-06-2025 | 08-06-2025 | 11-05-2025 | 02-25-2026 | |
| Assets | |||||||||
| Total Assets | 9.736 B | 10.099 B | 12.971 B | 13.055 B | 13.022 B | 13.489 B | 13.272 B | 13.697 B | |
| Current Assets | 4.171 B | 4.516 B | 6.728 B | 6.285 B | 6.213 B | 6.577 B | 6.359 B | 6.739 B | |
| Inventories | 1.207 B | 1.025 B | 1.104 B | 1.087 B | 1.114 B | 1.142 B | 1.141 B | 1.126 B | |
| Other Current Assets | 250.600 M | 252.100 M | 231.000 M | 347.600 M | 304.500 M | 314.400 M | 323.400 M | 339.300 M | |
| Short Term Investments | 473.000 M | 345.300 M | 769.700 M | 930.700 M | 757.900 M | 789.400 M | 1.156 B | 1.288 B | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.225 B | 1.645 B | 3.676 B | 3.045 B | 3.141 B | 3.273 B | 2.686 B | 2.938 B | |
| Total Non-current Assets | 455.600 M | 353.300 M | 319.600 M | 307.900 M | 277.900 M | 298.500 M | 274.700 M | 278.600 M | |
| Property Plant Equipment | 1.768 B | 1.640 B | 1.676 B | 1.686 B | 1.698 B | 1.727 B | 1.743 B | 1.812 B | |
| Other Assets | 3.798 B | 3.943 B | 4.568 B | 5.084 B | 5.111 B | 5.185 B | 5.170 B | 5.146 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 9.736 B | 10.099 B | 12.971 B | 13.055 B | 13.022 B | 13.489 B | 13.272 B | 13.697 B | |
| Total liabilities | 2.550 B | 2.595 B | 3.360 B | 2.992 B | 2.831 B | 2.882 B | 3.067 B | 3.360 B | |
| Total current liabilities | 1.111 B | 1.217 B | 1.944 B | 1.505 B | 1.395 B | 1.405 B | 1.588 B | 1.814 B | |
| Accounts Payable | 212.300 M | 185.900 M | 172.800 M | 197.400 M | 172.400 M | 162.100 M | 165.000 M | 227.500 M | |
| Other liabilities | 346.100 M | 258.200 M | 323.700 M | 373.300 M | 357.600 M | 379.200 M | 362.600 M | 362.300 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 597.200 M | 597.300 M | 597.500 M | 597.700 M | 597.800 M | 598.000 M | 598.200 M | 598.300 M | |
| Other liabilities | 346.100 M | 258.200 M | 323.700 M | 373.300 M | 357.600 M | 379.200 M | 362.600 M | 362.300 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 7.118 B | 7.437 B | 9.546 B | 9.998 B | 10.129 B | 10.545 B | 10.205 B | 10.338 B | |
| Common stock | 3.032 B | 3.130 B | 3.106 B | 3.268 B | 3.309 B | 3.408 B | 3.356 B | 3.427 B | |
| Retained earnings | 9.344 B | 9.711 B | 12.781 B | 13.167 B | 13.525 B | 13.858 B | 14.149 B | 14.241 B |